• Researchers Develop Tool to Detect Alzheimer’s Biomarkers in Several Body Fluids Simultaneously
  • Alzheimer’s Foundation Plans 2018 National ‘Educating America’ Tour
  • DrugPredict Wins $2.8M NIH Grant to Repurpose Approved Therapies to Treat Alzheimer’s
  • Researchers Abandon Idalopirdine as Alzheimer’s Treatment After Phase 3 Failures
  • ProMIS Alzheimer’s Therapy Attacks Only Harmful Brain Protein, Unlike Other Treatments, Study Finds
  • Takeda and Denali Partnering on Development of Three Alzheimer’s Therapies
  • Servier and Treventis Teaming Up to Develop Therapies That Can Circumvent Protein Misfolding
  • Diabetes Therapy Could Be Used to Treat Alzheimer’s, Study Reports
  • First Participants Dosed in a Phase 1 Clinical Trial of COR388
  • Eisai and Biogen to Continue Phase 2 Alzheimer’s Therapy Trial  for Six More Months
  • Top 10 Alzheimer’s Disease Stories of 2017
  • Pain Therapeutics’ Protein-targeting Alzheimer’s Therapy Is Safe, Phase 1 Trial Indicates